8-Oxoguanine DNA Glycosylase (OGG1) (C-Term) Peptide
Quick Overview for 8-Oxoguanine DNA Glycosylase (OGG1) (C-Term) Peptide (ABIN8093705)
Target
Origin
Source
Application
-
-
Protein Region
- C-Term
-
Purpose
- OGG1 Peptide - C-terminal region
-
Sequence
- AVPVDVHMWH IAQRDYSWHP TTSQAKGPSP QTNKELGNFF RSLWGPYAGW
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-OGG1 Antibody (ARP61228_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- OGG1 (8-Oxoguanine DNA Glycosylase (OGG1))
-
Background
-
Background Information: This gene encodes the enzyme responsible for the excision of 8-oxoguanine, a mutagenic base byproduct which occurs as a result of exposure to reactive oxygen. The action of this enzyme includes lyase activity for chain cleavage. Alternative splicing of the C-terminal region of this gene classifies splice variants into two major groups, type 1 and type 2, depending on the last exon of the sequence. Type 1 alternative splice variants end with exon 7 and type 2 end with exon 8. All variants share the N-terminal region in common, which contains a mitochondrial targeting signal that is essential for mitochondrial localization.
Alternative Symbols: HMMH, HOGG1, MUTM, OGH1
-
Molecular Weight
- 35kDa
-
Gene ID
- 4968
-
NCBI Accession
- NP_058438
-
UniProt
- O15527
Target
-